Drug
Parsaclisib
Parsaclisib: highest development phase Phase 3, developed by Incyte. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Incyte
Trials
| Drug | Phase | Indication |
|---|---|---|
| parsaclisib NCT04551053 | Phase 3 | Myelofibrosis |
| parsaclisib NCT04551066 | Phase 3 | Myelofibrosis |
| parsaclisib NCT04831996 | Phase 1 | Advanced Malignancies |
Latest
No recent events.
Follow Parsaclisib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.